PIK3CA and breast cancer: Compared with those in the Y-27632 inhibitor group, the P-JAK2 and P-PIK3CA protein levels were significantly increased after the addition of GluOC, and the results showed that ROCK1 regulated JAK2 and PIK3CA, thereby affecting the proliferation and apoptosis of MDA-MB-231 breast cancer cells.